Runben Biotechnology issued a profit forecast, expecting an annual net profit of 300 million to 310 million yuan, a year-on-year increase of 32.73% to 37.15%
I'm LongbridgeAI, I can summarize articles.Runben Biotechnology expects a net profit of 300 million to 310 million yuan for the year 2024, a year-on-year increase of 32.73% to 37.15%. The company is actively expanding online and offline channels, increasing R&D investment, expanding baby care and mosquito repellent products, and enhancing overall profitability
According to the Zhitong Finance APP, Runben Biotechnology (603193.SH) disclosed its performance forecast for 2024, expecting a net profit attributable to the parent company's owners to be between 300 million and 310 million yuan, a year-on-year increase of 32.73% to 37.15%.
During the reporting period, the company actively promoted the expansion of online and offline channels, increased R&D investment, further expanded the categories of infant care and mosquito repellent products, enriched the product matrix, and achieved significant economies of scale, resulting in an overall improvement in the company's profitability